Chemokines: Therapeutic targets for autoimmune and inflammatory renal disease

Springer Seminars in Immunopathology

Volumn 24, Issue 4, 2003, Pages 411-421

  Kelley, Vicki Rubin ^a   Rovin, Brad H ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CELL ADHESION MOLECULE; CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR; CX3C CHEMOKINE; CYSTEINE; CYTOKINE; G PROTEIN COUPLED RECEPTOR; GAMMA CHEMOKINE; INTEGRIN; LIGAND; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; SELECTIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; AUTOIMMUNE DISEASE; BLOOD VESSEL WALL; CHEMOTAXIS; DNA POLYMORPHISM; DRUG TARGETING; HOMEOSTASIS; IMMUNOLOGY; INFLAMMATION; KIDNEY DISEASE; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR BLOCKING; REVIEW; TISSUE INJURY;

ANIMALS; AUTOIMMUNE DISEASES; CHEMOKINES; DRUG DELIVERY SYSTEMS; HUMANS; NEPHRITIS;

EID: 0038349943     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-003-0124-4     Document Type: Review

References (61)

1. Abdi R, Huong TTB, Sahagun-Ruiz A, et al (2002) Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 13:754
2. Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, et al (2001) MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 58:335
3. Akalin E, Murphy B (2001) Gene polymorphisms and transplantation. Curr Opin Immunol 13:572
4. Anders H-J, Vielhauer V, Kretzler M, et al (2001) Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis. J Am Soc Nephrol 12:919
5. Bird JE, Giancarli MR, Kurihara T, et al (2000) Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice. Kidney Int 57:129
6. Birmingham DJ, Rovin BH, Yu CY, et al (2001) Of mice and men: the relevance of the mouse to the study of human SLE. Immunol Res 24:211
7. Bishop-Bailey D (2000) Peroxisome proliferator-activated receptors in the cardiovascular system. Br J Pharm 129:823
8. Boring L, Gosling J, Chensue SW, et al (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100:2522
9. Chen S, Bacon KB, Li L, et al (1998) In vivo inhibition of CC and CX3 C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med 188:193
10. Clynes R, Dumitru C, Ravetch JV (1998) Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279:1052
11. Feng L, Chen S, Garcia GE, et al (1999) Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1. Kidney Int 56:612
12. Fischereder M, Luckow B, Hocher B, et al (2001) CC chemokine receptor 5 and renal-transplant survival. Lancet 367:1758
13. Fukushima M (1992) Biological activities and mechanisms of action of PGJ2 and related compounds: an update. Prostaglandins Leukot Essent Fatty Acids 47:1
14. Gerard C, Rollins BJ (2001) Chemokines and disease. Nat Immunol 2:108
15. Grone H-J, Weber C, Weber KSC, et al (1999) Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J 13:1371
16. Hirata Y, Hayashi H, Ito S, et al (1988) Occurrence of 9-deoxy-delta 9,12-13,14-dihydroprostaglandin D2 in human urine. J Biol Chem 263:16619
17. Hora K, Satriano JA, Santiago A, et al (1992) Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide-1 and colony stimulating factor-1. Proc Natl Acad Sci USA 89:1745
18. Horuk R, Shurey S, Ng HP, et al (2001) CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model. Immunol Lett 76:193
19. + dendritic cells in murine lupus and preferential chemotaxis of B 1 cells towards BLC. J Exp Med 193:1393
20. Izikson L, Klein RS, Charo IF, et al (2000) Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor CCR2. J Exp Med 192:1075
21. Kroeger KM, Carville KS, Abraham LJ (1997) The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34:391
22. Lazarus M, Hajeer AH, Turner D, et al (1997) Genetic variation in the interleukin-10 gene promoter and systemic lupus erythematosus. J Rheumatol 24:2314
23. Liu H, Chao D, Nakayama E, et al (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 96:4581
24. Lu B, Rutledge BJ, Gu L, et al (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein-1 deficient mice. J Exp Med 187:601
25. Mackay CR (2001) Chemokines: immunology's high impact factors. Nat Immunol 2:95
26. Magnusson V, Nakken B, Bolstad AI, et al (2001) Cytokine polymorphisms in systemic lupus erythematosus and Sjogren's syndrome. Scan J Immunol 54:55
27. Marsh CB, Lowe MP, Rovin BH, et al (1998) Lymphocytes produce IL-1B in response to Fc gamma receptor cross-linking: effects on parenchymal cell IL-8 release. J Immunol 160:3942
28. Marsh CB, Wewers MD, Tan LC, et al (1997) FcgammaR cross-linking induces peripheral blood mononuclear cell MCP-1 expression: role of lymphocyte FcgammaR 111. J Immunol 158:1078
29. McGuire W, Hill AVS, Allsopp CEM, et al (1994) Variation in the TNF-alpha promoter region association with susceptibility to cerebral malaria. Nature 371:508
30. Moore KJ, Wada T, Barbee SD, et al (1998) Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(1pr) mice. Kidney Int 53:1631
31. Okada H, Moriwaki K, Kalluri R, et al (2000) Inhibition of monocyte chemoattractant protein-1 expression in tubular epithelium attenuates tubulointerstitial alteration in rat Goodpasture syndrome. Kidney Int 57:927
32. Panzer U, Schneider A, Wilken J, et al (1999) The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis. Kidney Int 56:2107
33. Park SY, Ueda S, Ohno H, et al (1998) Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J Clin Invest 102:1229
34. Perez de Lema G, Maier H, Nieto E, et al (2001) Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 12:1369
35. Radeke HH, Gessner JE, Uciechowski P, et al (1994) Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFcgRIII-A) and the associated FcεRI γ-chain. J Immunol 153:1281
36. Reilly CM, Oates JC, Cook JA, et al (2000) Inhibition of mesangial cell nitric oxide in MRL/Ipr mice by prostaglandin J2 and proliferator activation receptor gamma agonists. J Immunol 164:1498
37. Ricote M, Li AC, Willson TM, et al (1998) The peroxisome proliferator-activate receptor-gamma is a negative regulator of macrophage activation. Nature 391:79
38. Romagnani P, Beltrame C, Annunziato F, et al (1999) Role for interactions between IP-10/Mig and CXCR3 in proliferative glomerulonephritis. J Am Soc Nephrol 10:2518
39. Rovin BH (2000) Chemokine blockade as a therapy for renal disease. Curr Opin Nephrol Hyperten 13:225
40. Rovin BH, Lu L (2000) Role of chemokine polymorphisms in determining the severity of renal inflammation in SLE. J Am Soc Nephrol 11:96A
41. Rovin BH, Lu L, Cosio AM (2001) Cyclopentenone prostaglandins inhibit cytokine-induced NF-kappaB activation and chemokine production by human mesangial cells. J Am Soc Nephrol 12:1659
42. Rovin BH, Lu L, Marsh CB (2001) Lymphocytes induce monocyte chemoattractant protein-1 production by renal cells after Fcgamma receptor cross-linking: role of IL-1beta. J Leukoc Biol 69:435
43. Rovin BH, Lu L, Saxena R (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259:344
44. Rovin BH, Lu L, Zhang X (2002) A novel interleukin-8 polymorphism is associated with severe SLE nephritis. Kidney Int (in press)
45. Rovin BH, Phan LT (1998) Chemotactic factors and renal inflammation. Am J Kidney Dis 31:1065
46. Santiago A, Mori T, Satriano J, et al (1991) Regulation of Fc receptors for IgG on cultured rat mesangial cells. Kidney Int 39:87
47. Satriano J, Schlondorff D (1994) Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumor necrosis factor-α, immunoglobulin G, and adenosine 3′:5′-cyclic monophosphate. J Clin Invest 94:1629
48. Satriano JA, Hora K, Shan Z, et al (1993) Regulation of monocyte chemoattractant protein-I and macrophage colony-stimulating factor-1 by IFN-gamma, tumor necrosis factor-alpha, IgG aggregates, and cAMP in mouse mesangial cells. J Immunol 150:1971
49. Satriano JA, Shuldner M, Hora K, et al (1993) Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. J Clin Invest 92:1564
50. Savill J (1999) Regulation of glomerular cell number by apoptosis. Kidney Int 56:1216
51. Schocklmann HO, Lang S, Sterzel RB (1999) Regulation of mesangial cell proliferation. Kidney Int 56:1199
52. Shibata T, Kondo M, Osawa T, et al (2002) 15-Deoxy-delta 12,14-prostaglandin J2: a prostaglandin D2 metabolite generated during inflammatory processes. J Biol Chem 277:10459
53. Shinozaki M, Hirahashi J, Lebedeva T, et al (2002) IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. J Clin Invest 109:951
54. Tesch GH, Maifert S, Schwarting A, et al (1999) Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-faslpr mice. J Exp Med 190:1813
55. Tesch GH, Schwarting A, Kinoshita K, et al (1999) Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 103:73
56. Teuscher C, Butterfield RJ, Ma RZ, et al (1999) Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonorelapsing experimental allergic encephalomyelitis. J Immunol 163:2262
57. Thelen M (2001) Dancing to the tune of chemokines. Nat Immunol 2:129
58. Topham P, Csizmadia V, Soler D, et al (1999) Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest 104:1549
59. Turner DM, Williams DM, Sankaran D, et al (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1
60. Uciechowski P, Schwarz M, Gessner JE, et al (1998) IFN-gamma induces the high affinity Fc receptor I for IgG (CD64) on human glomerular mesangial cells. Eur J Immunol 28:2928
61. Wilson AG, Symons JA, McDowell TL, et al (1997) Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195